Development of new oral cyclosporine formulation using cyclodextrin tetrapolymer (P-αβγ-CD) in attempt to enhance its stability and dissolution rate.Two spray-dried dispersion formulations containing poorly water-soluble cyclosporine (CsA) were prepared with cyclodextrin tetrapolymer in water (F H2O ) and ethanol (F EOH ) then characterized by scanning electron microscopy, powder X-ray diffraction, particle size distribution, circular dichroism and nuclear magnetic resonance (NMR) along with the dissolution study which was compared to Neoral® and Sandimmune®. The physicochemical characterization studies showed an interaction between cyclosporine and P-αβγ-CD without secondary structure changes of cyclosporine. The order of cyclosporine rele...
The investigation of the usability of solid insoluble β-cyclodextrin polymers (βCDP) in micro-sized,...
Cefdinir (CFD) is an oral cephalosporin antibiotic commonly used in the treatment of community-acqui...
Formulation and characterization approach of cyclospirin-A in nanoemulsified composites
International audienceCyclosporine (CsA) has a selective property of suppressing various T-lymphocyt...
This study aimed to develop a cyclosporine A (CsA)-loaded ternary solid dispersion (tSD/CsA) to impr...
The objective of this research was to explore two formulation strategies—hydrotropic solubilization ...
Cyclodextrins (CDs) are cyclic oligosaccharides that form inclusion complexes with lipophilic molecu...
The concept of solid dispersion was proposed by Sekiguchi and Obi in the early 1960’s, who investiga...
This study aims to improve the dissolution of inhalable cyclosporine A nanoparticles by formulating ...
A novel supersaturable self-emulsifying drug delivery system (S-SEDDS) of cyclosporine A (CyA)—a poo...
Three different methods (evaporation, spray-drying and lyophilisation) were used to prepare the comp...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
For lung transplant patients, a respirable, inulin-based solid dispersion containing cyclosporine A ...
Glimepiride is an oral antidiabetic drugs which is practically insoluble in water. The formation of ...
The investigation of the usability of solid insoluble β-cyclodextrin polymers (βCDP) in micro-sized,...
Cefdinir (CFD) is an oral cephalosporin antibiotic commonly used in the treatment of community-acqui...
Formulation and characterization approach of cyclospirin-A in nanoemulsified composites
International audienceCyclosporine (CsA) has a selective property of suppressing various T-lymphocyt...
This study aimed to develop a cyclosporine A (CsA)-loaded ternary solid dispersion (tSD/CsA) to impr...
The objective of this research was to explore two formulation strategies—hydrotropic solubilization ...
Cyclodextrins (CDs) are cyclic oligosaccharides that form inclusion complexes with lipophilic molecu...
The concept of solid dispersion was proposed by Sekiguchi and Obi in the early 1960’s, who investiga...
This study aims to improve the dissolution of inhalable cyclosporine A nanoparticles by formulating ...
A novel supersaturable self-emulsifying drug delivery system (S-SEDDS) of cyclosporine A (CyA)—a poo...
Three different methods (evaporation, spray-drying and lyophilisation) were used to prepare the comp...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
For lung transplant patients, a respirable, inulin-based solid dispersion containing cyclosporine A ...
Glimepiride is an oral antidiabetic drugs which is practically insoluble in water. The formation of ...
The investigation of the usability of solid insoluble β-cyclodextrin polymers (βCDP) in micro-sized,...
Cefdinir (CFD) is an oral cephalosporin antibiotic commonly used in the treatment of community-acqui...
Formulation and characterization approach of cyclospirin-A in nanoemulsified composites